The FDA approved the first generic dapagliflozin tablets, opening a competitive US market for pharma manufacturers and ...
Generic dapagliflozin is indicated to lower heart failure hospitalization risk in type 2 diabetes with established cardiovascular disease or multiple risk factors, and to improve glycemic control ...
Multiple manufacturers receive FDA approval for generic dapagliflozin to treat type 2 diabetes and lower heart failure risks in high-risk T2D patients.
MedPage Today on MSN
FDA Approves First Farxiga Generics for Type 2 Diabetes
Generics gain indications for glycemic control, reducing heart failure hospitalization ...
Children aged 10 years and older with type 2 diabetes can now improve their glycemic control with a drug previously only approved for adults. After 26 weeks of treatment, results showed that ...
The approval by the US Food and Drug Administration (USFDA) is for dapagliflozin tablets of strengths 5 mg and 10 mg, Biocon said in a regulatory filing ...
Biocon Pharma, a subsidiary of Biocon, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Dapagliflozin Tablets, 5 mg and 10 mg.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results